Home » Topics » BioWorld Science

BioWorld Science
RSS

GSK and Lyell Immunopharma collaborate to improve cell therapies for cancer

Oct. 9, 2019

Scenesse wins approval in U.S. for erythropoietic protoporphyria

Oct. 9, 2019

Tezepelumab reduces activation of matrix remodeling and inflammatory pathways

Oct. 9, 2019

FDA approves Wilate for hemophilia A

Oct. 9, 2019

MTPS-9579A dose-dependently inactivates airway tryptase for the treatment of asthma

Oct. 9, 2019

MinL4.0 RSV: a synthetic, live-attenuated vaccine against respiratory syncytial virus

Oct. 9, 2019

Preliminary data presented from phase I/II ASPIRO study of AT-132

Oct. 9, 2019

Selepressin does not improve vasopressor- and ventilator-free days in patients with septic shock

Oct. 9, 2019

Discovery of novel potent fully human FVIII mimetic BiAb, KY-1049

Oct. 9, 2019

New mouse model of diabetic cystopathy described

Oct. 9, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...